[Treatment of lymphangioma with OK432 in children].
From 1998 to 2003 6 children with lymphangioma of cervico-facial region were treated with OK-432 in Polish Mother Health Institute. Three of them had nonresectable leasion and two required tracheostomy during first months of life. Each patient received from 1 to 10 sessions of obliteration. In total 23 sessions were performed. The youngest patient treated with OK-432 was 2 weeks and the oldest 2 years old. The response to treatment was very good in 4, good in 1 and fairly good in 1 case. In three patients criodestruction was applied as an additional treatment. In two children residual lesions were subsequently removed surgically. There were no serious complications. After obliteration sessions only 2-3 day temperature increase and local inflammation occurred. We consider obliteration with OK-432 as a treatment of choice in lymphangiomas in children.
Makowski
Andrzej
A
Klinika Otolaryngologii Instytutu Centrum Zdrowia Matki Polki w Lodzi.
Apanasiewicz
Artur
A
Chilarski
Andrzej
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D015552:Injections, Intralesional; D008202:Lymphangioma / Q000188:drug therapy*; D008297:Male; D010844:Picibanil / Q000627:therapeutic use*; D011044:Poland; D012189:Retrospective Studies; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D010844:Picibanil